Atlas Trials

Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa

Clinical trial NCT04285294 · UNKNOWN

Trial details

NCT number
NCT04285294
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
Recessive Dystrophic Epidermolysis Bullosa
Start date
2020-03-01
Primary completion
2023-12-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.